1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diffuse Parenchymal Lung Disease

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nakatsuji, T	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diffuse Parenchymal Lung Disease

Article	Year
Alpha 1 antitrypsin defective Lewis rats injected with heparin: comparison of the glomerular changes with those of Lewis rats produced anti BSA antibody. The Keio journal of medicine, 1996, Volume: 45, Issue:2 Topics: alpha 1-Antitrypsin Deficiency; Animals; Antibodies; Chemotaxis, Leukocyte; Female; Heparin; Immunoglobulin G; Kidney Glomerulus; Liver; Lung Diseases, Interstitial; Male; Platelet Activating Factor; Rats; Rats, Inbred Lew; Serum Albumin, Bovine	1996

Article

Year

Alpha 1 antitrypsin defective Lewis rats injected with heparin: comparison of the glomerular changes with those of Lewis rats produced anti BSA antibody.

The Keio journal of medicine, 1996, Volume: 45, Issue:2

Topics: alpha 1-Antitrypsin Deficiency; Animals; Antibodies; Chemotaxis, Leukocyte; Female; Heparin; Immunoglobulin G; Kidney Glomerulus; Liver; Lung Diseases, Interstitial; Male; Platelet Activating Factor; Rats; Rats, Inbred Lew; Serum Albumin, Bovine

1996